Medical Treatment of Fibroid to Decrease Rate of Hysterectomy
By Mohamed Y. Abdel-Rahman, Mohamed Sabry and Ayman Al-Hendy
- Dr. Ayman Al-Hendy
Update my profile »
- Dr Al-Hendy graduated from Banha Faculty of Medicine, Zagazig University, Egypt in 1986. After 1 years of internship in Banha University Hospital, and earning his PhD from University of Turku, Finland, he gained additional postdoctoral training in gene therapy and clinical molecular genetics at McMaster University and McGill University in Canada, completed the clinical residency training in Obstetrics and Gynecology at University of Saskatchewan, and fellowship training in laparoscopic surgery at Toronto University, both in Canada. In USA, Dr. Al-Hendy held various faculty positions at University of Texas Medical Branch before moving to Nashville in Tennessee, where he currently holds the positions of Professor and Vice Chair of the Department of Obstetrics and Gynecology, Scientific Director of the Center of Women Health Research at Meharry Medical College, and Adjunct professor at Vanderbilt University, and Vanderbilt University Medical Center. Dr. Al-Hendy\'s medical research interests focus on developing novel therapies including gene and stem cell therapy for Premature Ovarian Failure, Endometriosis, and Uterine Fibroids. He is currently researching the utility of various nutritional supplements as possible non-surgical therapy for this uterine fibroids. In 2010 he was awarded the American Society of Reproductive Medicine’s 2010 Ira and Ester Rosenwaks Award for his significant contribution to the field of translational Reproductive Biology.